I. Muñiz

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Emilio Esteban, Luis González de Sande, Yolanda Fernández et al. · Annals of Oncology · 2003 · 54 citations · Full text

Medicine, Oncology, Pharmacology +14

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study

Emilio Esteban, N. Villanueva, I. Muñiz et al. · Investigational New Drugs · 2007 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

Emilio Esteban, J. Fra, Yolanda Fernández et al. · Investigational New Drugs · 2005 · 15 citations

Medicine, Oncology, Pharmacology +13

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

R. Sosa Sanchez, Emilio Esteban, Isabel Palacio et al. · Investigational New Drugs · 2003 · 13 citations

Medicine, Oncology, Pharmacology +14

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

Emilio Esteban, A.J. Lacave, Jorge Lázaro Loys Fernández et al. · Breast Cancer Research and Treatment · 1999 · 10 citations

Medicine, Oncology, Pharmacology +16